Simplera Sync Sensor, Guardian 4 Sensor
Medtronic MiniMed, Inc. · Decision date Aug 6, 2025
What did the FDA approve?
FDA records P250012 as an original PMA application. The recorded decision is approval, dated Aug 6, 2025.
FDA approval order statement
Approval of the Simplera Sync sensor and Guardian 4 sensor, intended to function as components of a Medtronic automated insulin dosing system.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Clinical Chemistry
- Decision date
- Aug 6, 2025
Regulatory record facts
- Identifier
- P250012
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- SFI
- Decision code
- APPR
- Decision date
- Aug 6, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sensor, Glucose, Invasive, Component of automated insulin delivery system.
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- SFI
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P250012 received
Application receipt date recorded by FDA.
P250012 · FDA decision
APPR
P250012/S001 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S003 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S002 · Related supplement
Guardian 4 Sensor
P250012/S004 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S006 · Related supplement
Simplera Sync Sensor
P250012/S007 · Related supplement
Simplera Sync Sensor
P250012/S005 · Related supplement
Simplera Sync Sensor; Guardian 4 Sensor
P250012/S009 · Related supplement
Simplera Sync Sensor
P250012/S010 · Related supplement
Simplera and Simplera Sync
P250012/S008 · Related supplement
Simplera Sync Sensor
P250012/S011 · Related supplement
Simplera Sync
Timeline entries are records held by MedtechLedger for P250012. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250012
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic MiniMed, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 18000 Devonshire St., Northridge, CA, 91325
Sources and methodology
- Original FDA record: P250012
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






